Clinical Trial Update: Hetrombopag for the Prevention of ADC-Induced Thrombocytopenia in Breast Cancer: An Exploratory, Dual-Cohort, Phase 2 Study [Phase 2]

View source ↗

Summary

Phase 2 exploratory trial evaluating hetrombopag to prevent chemotherapy-induced thrombocytopenia in breast cancer patients, conducted in dual cohorts and not y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Chemotherapy-induced Thrombocytopenia

Drugs mentioned

• Hetrombopag (hetrombopag)

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: CTIT-Chemotherapy Induced Thrombocytopenia, Breast Cancer | Phase 2 | Status: NOT_YET_RECRUITING